A Peer-based Mobile-health Intervention to Increase Access & Adherence to Hepatitis C Treatment & HIV Viral Suppression (HCV-TTP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02772328 |
Recruitment Status :
Active, not recruiting
First Posted : May 13, 2016
Last Update Posted : August 28, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hepatitis C HIV Risk Reduction Behavior | Behavioral: Peer Mentor | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 300 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Investigator, Outcomes Assessor) |
Primary Purpose: | Screening |
Official Title: | Randomized Controlled Trial of a Social-network Oriented Mobile Health Based Intervention to Increase Access and Adherence to Hepatitis C Treatment and HIV Viral Suppression |
Actual Study Start Date : | December 19, 2016 |
Estimated Primary Completion Date : | August 2020 |
Estimated Study Completion Date : | August 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Peer Mentor
Individuals in this arm will be trained in communication skills to promote HIV and HCV testing to their social network members, linkage to care and risk reduction behaviors.
|
Behavioral: Peer Mentor
comparison of communication training to equal attention control |
No Intervention: Neighborhood Matters
Participants in this arm will view a 15-20 minute video on issues in neighborhoods such as crime and violence, restoring communities and incarceration and discuss their reactions and thoughts.
|
- Continuity in HIV care scale [ Time Frame: 24 months ]
- Access to HCV care scale [ Time Frame: 24 months ]Initiation of HCV care at a viral hepatitis clinic
- HIV medication adherence scale [ Time Frame: 24 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- HCV antibody positive
- HIV antibody positive
- lifetime history of injection drug use
- interrupted HIV care:>3 months since HIV care or detectable viral load
- willingness to participate in group sessions and have conversations with social network members
Exclusion Criteria:
- participated in a behavioral intervention in prior 2 years

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02772328
United States, Maryland | |
Lighhouse Studies @ Peer Point | |
Baltimore, Maryland, United States, 21205 |
Principal Investigator: | Carl A Latkin, PhD | Johns Hopkins Bloomberg School of Public Health | |
Principal Investigator: | Karin E Tobin, PhD | Johns Hopkins Bloomberg School of Public Health |
Responsible Party: | Johns Hopkins Bloomberg School of Public Health |
ClinicalTrials.gov Identifier: | NCT02772328 |
Other Study ID Numbers: |
1R01DA040488 ( U.S. NIH Grant/Contract ) |
First Posted: | May 13, 2016 Key Record Dates |
Last Update Posted: | August 28, 2019 |
Last Verified: | August 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | Will work with NIH to determine sharing plan |
Testing Access |
Hepatitis A Hepatitis C Hepatitis Liver Diseases Digestive System Diseases Hepatitis, Viral, Human |
Virus Diseases Enterovirus Infections Picornaviridae Infections RNA Virus Infections Flaviviridae Infections |